LTR PHARMA LIMITED - Corporate Spotlight

Market Cap $150.0M Add to my watchlist

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No Corporate Spotlight currently available.

(20min delay)
Last $1.22		Change -0.010(0.82%)		Mkt cap ! $150.0M

Open	High	Low	Value	Volume
$1.25	$1.26	$1.21	$350.6K	285.3K

Buyers (Bids)

No.	Vol.	Price($)
1	267	$1.22

Sellers (Offers)

Price($)	Vol.	No.
$1.27	790	1

View Market Depth

No.	Vol.	Price($)
1	1246	1.605
1	625	1.600
1	1257	1.590
2	12954	1.575
1	2954	1.565

Price($)	Vol.	No.
1.615	2872	2
1.620	2954	1
1.630	5683	2
1.640	273	1
1.650	5606	2

Last trade - 16.10pm 22/11/2024 (20 minute delay)


Last $1.21		Change -0.010 ( 2.81 %)
Open	High	Low	Volume
$1.26	$1.26	$1.21	47965
Last updated 15.59pm 22/11/2024 ?

LTP (ASX) Chart